Acute systemic reactions to sublingual immunotherapy for house dust mite.
作者信息
Janssens Nicky S, van Ouwerkerk Lotte, Gerth van Wijk Roy, Karim Faiz
机构信息
Department of Internal Medicine, Groene Hart Hospital, Gouda, the Netherlands.
Department of Internal Medicine, Section Allergy and Clinical Immunology, Erasmus Medical Centre, Rotterdam, the Netherlands.
出版信息
Allergy. 2020 Nov;75(11):2962-2963. doi: 10.1111/all.14417. Epub 2020 Jun 15.
Abstract
摘要
相似文献
1
Acute systemic reactions to sublingual immunotherapy for house dust mite.
Allergy. 2020 Nov;75(11):2962-2963. doi: 10.1111/all.14417. Epub 2020 Jun 15.
2
Clinical benefits of treatment with SQ house dust mite sublingual tablet in house dust mite allergic rhinitis.
Allergy. 2017 Oct;72(10):1576-1578. doi: 10.1111/all.13155. Epub 2017 Apr 11.
3
Sublingual immunotherapy (SLIT) for house dust mite - when to take a break?: An unusual reaction to SLIT post vaccinations.
Ann Allergy Asthma Immunol. 2023 Jun;130(6):809-810. doi: 10.1016/j.anai.2023.03.008. Epub 2023 Mar 15.
4
Improvements with sublingual house dust mite immunotherapy in allergic rhinitis.
J Allergy Clin Immunol. 2016 Aug;138(2):634-5. doi: 10.1016/j.jaci.2016.03.033. Epub 2016 May 24.
5
A Three-Year Course of House Dust Mite Sublingual Immunotherapy Appears Effective in Controlling the Symptoms of Allergic Rhinitis.
Am J Rhinol Allergy. 2018 May;32(3):147-152. doi: 10.1177/1945892418764966. Epub 2018 Apr 12.
6
Safety and tolerability of the standardized quality house dust mite sublingual immunotherapy tablet in real life: A noninterventional, open-label study.
J Allergy Clin Immunol Pract. 2021 Aug;9(8):3221-3223.e5. doi: 10.1016/j.jaip.2021.03.045. Epub 2021 Apr 8.
7
Odactra--sublingual immunotherapy for house dust mite-induced allergic rhinitis.
Med Lett Drugs Ther. 2018 Feb 26;60(1541):37-39.
8
The SQ House Dust Mite SLIT-Tablet Is Well Tolerated in Patients with House Dust Mite Respiratory Allergic Disease.
Int Arch Allergy Immunol. 2017;174(1):35-44. doi: 10.1159/000478699. Epub 2017 Sep 27.
9
Early increase in serum specific IgG2 upon allergen immunotherapy with a 300 IR sublingual house dust mite tablet.
Allergy. 2023 Jul;78(7):2040-2043. doi: 10.1111/all.15685. Epub 2023 Mar 9.
10
Efficacy and safety of the SQ house dust mite sublingual immunotherapy tablet in Japanese adults and adolescents with house dust mite-induced allergic rhinitis.
J Allergy Clin Immunol. 2017 Jun;139(6):1840-1848.e10. doi: 10.1016/j.jaci.2016.09.043. Epub 2016 Nov 15.
引用本文的文献
1
Safety of 300IR house dust mite sublingual tablet from pooled clinical trial and post-marketing data.
World Allergy Organ J. 2024 Jun 25;17(7):100924. doi: 10.1016/j.waojou.2024.100924. eCollection 2024 Jul.
2
Characteristics of dust mite sublingual immunotherapy-associated adverse events in the early phase.
Front Med (Lausanne). 2022 Dec 2;9:1015032. doi: 10.3389/fmed.2022.1015032. eCollection 2022.
3
The SQ HDM SLIT-Tablet is safe and well tolerated in patients with House Dust Mite allergic rhinitis with or without asthma: A "real-life" French study.
Clin Transl Allergy. 2022 Mar;12(3):e12129. doi: 10.1002/clt2.12129.
4
Gaps in allergen immunotherapy administration and subcutaneous allergen immunotherapy dose adjustment schedules: Need for prospective data.
Ann Allergy Asthma Immunol. 2020 Nov;125(5):505-506.e2. doi: 10.1016/j.anai.2020.07.015. Epub 2020 Jul 18.
本文引用的文献
1
Acute emotional stress proposed as a risk factor for anaphylaxis in patients receiving allergen immunotherapy.
Ann Allergy Asthma Immunol. 2020 Apr;124(4):314-317. doi: 10.1016/j.anai.2020.01.006. Epub 2020 Jan 20.
2
Sublingual allergen immunotherapy for respiratory allergy: a systematic review.
Drugs Context. 2018 Nov 5;7:212552. doi: 10.7573/dic.212552. eCollection 2018.
3
Anaphylaxis and Clinical Utility of Real-World Measurement of Acute Serum Tryptase in UK Emergency Departments.
J Allergy Clin Immunol Pract. 2017 Sep-Oct;5(5):1280-1287.e2. doi: 10.1016/j.jaip.2017.06.021.
4
World Allergy Organization Systemic Allergic Reaction Grading System: Is a Modification Needed?
J Allergy Clin Immunol Pract. 2017 Jan-Feb;5(1):58-62.e5. doi: 10.1016/j.jaip.2016.11.009.
5
Epinephrine Use in Clinical Trials of Sublingual Immunotherapy Tablets.
J Allergy Clin Immunol Pract. 2017 Jan-Feb;5(1):84-89.e3. doi: 10.1016/j.jaip.2016.08.017. Epub 2016 Nov 9.
6
Treatment effect of sublingual immunotherapy tablets and pharmacotherapies for seasonal and perennial allergic rhinitis: Pooled analyses.
J Allergy Clin Immunol. 2016 Oct;138(4):1081-1088.e4. doi: 10.1016/j.jaci.2016.04.061. Epub 2016 Jul 15.
7
Subcutaneous versus sublingual immunotherapy for allergic rhinitis and/or asthma.
Immunotherapy. 2011 Jun;3(6):747-56. doi: 10.2217/imt.11.48.
8
Speaking the same language: The World Allergy Organization Subcutaneous Immunotherapy Systemic Reaction Grading System.
J Allergy Clin Immunol. 2010 Mar;125(3):569-74, 574.e1-574.e7. doi: 10.1016/j.jaci.2009.10.060. Epub 2010 Feb 7.
9
Seasonal variation in airway hyperresponsiveness and natural exposure to house dust mite allergens in patients with asthma.
J Allergy Clin Immunol. 1994 Feb;93(2):470-5. doi: 10.1016/0091-6749(94)90356-5.
Zotero 插件